United Kingdom · Question · Written question
HL HL2493
Antimicrobials: Drug Resistance
Introduced
11 March 2020
Last action
23 March 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 March 2020
Summary
To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 26 February (HL1925), (1) whether they will provide a breakdown of how the £360 million invested in antimicrobial resistance research since 2014 was spent, (2) what assessme
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 March 2020
Written question
To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 26 February (HL1925), (1) whether they will provide a breakdown of how the £360 million invested in antimicrobial resistance research since 2014 was spent, (2) what assessme
Source: Lords
23 March 2020
Answer
The breakdown of the United Kingdom’s investment into antimicrobial resistance (AMR) research and development since 2014 is set out in the following table:Investment amountItemUK domestic investment£46 millionUK Research and Innovation (UKRI): Cross-Resea...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-03-11/HL2493
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1184476
- uk · wq-1184476 · source updated 23 March 2020